- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 277/44 - Radicaux amino ou imino acylés
Détention brevets de la classe C07D 277/44
Brevets de cette classe: 84
Historique des publications depuis 10 ans
|
5
|
4
|
8
|
4
|
3
|
4
|
2
|
2
|
6
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 19812 |
6 |
| The Board of Trustees of the Leland Stanford Junior University | 6365 |
5 |
| Stemsynergy Therapeutics, Inc. | 19 |
4 |
| Glaxo Group Limited | 4132 |
3 |
| Syngenta Participations AG | 1919 |
3 |
| Glaxosmithkline Intellectual Property Development Limited | 753 |
2 |
| The Johns Hopkins University | 5642 |
2 |
| ARIAD Pharmaceuticals, Inc. | 49 |
2 |
| Astellas Pharma Inc. | 1086 |
2 |
| Nippon Soda Co., Ltd. | 891 |
2 |
| Shanghai Yao Yuan Biotechnology Co., Ltd. | 29 |
2 |
| Novartis AG | 10904 |
1 |
| Bristol-myers Squibb Company | 4892 |
1 |
| Genentech, Inc. | 3961 |
1 |
| Massachusetts Institute of Technology | 10013 |
1 |
| DSM IP Assets B.V. | 5659 |
1 |
| Abbvie Inc. | 1802 |
1 |
| Takeda Pharmaceutical Company Limited | 2704 |
1 |
| Vertex Pharmaceuticals Incorporated | 1596 |
1 |
| Adeka Corporation | 1359 |
1 |
| Autres propriétaires | 42 |